CSE/GRIN (CSE/GRIN)

Canadian Securities Exchange: CSE/GRIN · CAD

CA$0.48

+0.00 (+1.1%)· Recorded snapshot

Market cap	118.7M
Revenue (ttm)	53.5M
Net income (ttm)	-6.8M
EPS (ttm)	-CA$0.03
Shares out	249.9M
Volume	61,000
Beta	-1.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 53.5M
Net income (ttm): -6.8M
EPS (ttm): -CA$0.03
Market cap: 118.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-11.3

P25 n/aP50 n/aP75 n/a

ROIC1.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/GRIN indicators

Market & fundamental data

Available fields

192

Groups with data

Currency

USD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-12
Enterprise value	CAD 150.4M
Exchange	Canadian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1978
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA39986R3045
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2018-11-26
Last stock split type	Reverse
Market cap	CAD 118.7M
Next earnings date	2026-11-12
Price	CAD 0.48
Price currency	CAD
Sector	Healthcare
SIC code	0100
Stock price date	2026-10-28
Symbol	cse/GRIN
Website	https://www.grownrogue.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-5.89%
EV/EBITDA	133.05x
EV/Sales	2.79x
FCF / EV yield	-1.37%
FCF yield	-1.74%
Industry forward P/E	34.53x
P/(OCF - SBC) ratio	10.96x
P/B ratio	3.8x
P/OCF ratio	9.76x
P/S ratio	2.19x
Price / tangible book value	6.74x
Price/EBITDA ratio	65.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.65%
EBITDA margin	3.36%
Gross margin	43.07%
Operating margin	1.65%
Pretax margin	-3.77%
Profit margin	-12.64%
Profitable years	1
ROA	0.69%
ROCE	1.1%
ROE	-11.3%
ROIC	1.67%
ROIC (5Y)	14.95%
SBC / revenue	2.45%
Tax / revenue	3.82%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	34.08%
Gross profit growth (Q)	51.08%
Gross profit growth 3Y	25.97%
Gross profit growth 5Y	54.48%
Net income growth years	1
OCF growth (Q)	392.77%
OCF growth (QoQ)	-32.4%
OCF growth 3Y	61.71%
Operating income growth (Q)	93.96%
Operating income growth 3Y	-24.61%
Revenue growth	36.95%
Revenue growth (Q)	40.75%
Revenue growth (QoQ)	23.14%
Revenue growth 3Y	28.52%
Revenue growth 5Y	54.81%
Revenue growth quarters	3
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -14.1M
Depreciation and amortization	CAD 908,108
EBIT	CAD 881,689
EBITDA	CAD 1.8M
EPS	CAD -0.03
FCF per share	CAD -0.01
Financing cash flow	CAD 7.9M
Free cash flow	CAD -2M
Free cash flow minus SBC	CAD -3.4M
Gross profit	CAD 23.1M
Income taxes	CAD 2M
Investing cash flow	CAD -17.2M
Net borrowing	CAD 4.6M
Net cash flow	CAD 2.7M
Net income	CAD -6.8M
Operating cash flow minus SBC	CAD 10.7M
Operating income	CAD 881,689
Revenue	CAD 53.5M
Stock-based compensation	CAD 1.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.21
Book value per share	CAD 0.09
Debt / EBITDA	21.59
Debt / equity	1.26
Interest coverage	0.37
Long-term assets	CAD 60.6M
Long-term liabilities	CAD 49.2M
Net cash (debt)	CAD -22.5M
Net cash / market cap	-19.13%
Net debt / EBITDA	12.49
Net debt / equity	0.73
Piotroski F-Score	3
Property, plant and equipment	CAD 44.5M
Shareholders' equity	CAD 30.9M
Tangible book value	CAD 17.4M
Tangible book value per share	CAD 0.07
Total assets	CAD 92.3M
Total cash	CAD 16.4M
Total debt	CAD 38.8M
Total liabilities	CAD 61.4M
WACC	0.16%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.67
Current assets	CAD 31.7M
Current liabilities	CAD 12.2M
Current ratio	2.59
Inventory turnover	3.83
Net working capital	CAD 9.2M
Quick ratio	1.75
Working capital	CAD 19.7M
Working capital turnover	3.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-8.72%
Shareholder yield	-8.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.56
1D price change	1.06%
1M price change	-22.13%
1M total return	-22.13%
1W price change	-5%
1W total return	-5%
1Y price change	-8.65%
1Y return CAGR	-8.66%
1Y total return	-8.65%
20-day SMA	CAD 0.53
200-day SMA	CAD 0.54
3M price change	-8.65%
3M total return	-8.65%
3Y price change	18.75%
3Y return CAGR	5.89%
3Y total return	18.75%
50-day SMA	CAD 0.58
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 0.72
52-week high date	2026-01-02
52-week low	CAD 0.38
52-week low date	2026-03-27
5Y price change	251.85%
5Y return CAGR	28.61%
5Y total return	251.85%
6M price change	-4.04%
6M total return	-4.04%
All-time high	CAD 1.15
All-time high date	2024-05-17
All-time low	CAD 0.06
All-time low date	2019-11-14
Average true range (ATR)	CAD 0.03
Average volume	19.9K
Beta (1Y)	0.13
Beta (2Y)	1.28
Beta (5Y)	-1.02
Change from 52-week high	-34.03%
Change from 52-week low	25%
Change from all-time high	-58.7%
Change from all-time low	691.67%
Change from open	1.06%
Day's gap	0%
Dollar volume	CAD 28,975
High price	CAD 0.49
Low price	CAD 0.47
Monthly RSI	45.08
Open price	CAD 0.47
Position in 52-week range	25%
Previous close	CAD 0.47
Price vs 150-day SMA	-15.04%
Price vs 20-day SMA	-11.02%
Price vs 200-day SMA	-12.65%
Price vs 50-day SMA	-18.59%
Relative volume	3.07
RSI	34.24
Sharpe ratio	0.23
Sharpe ratio (3Y)	0.46
Sharpe ratio (5Y)	0.63
Sortino ratio	0.46
Sortino ratio (3Y)	0.78
Sortino ratio (5Y)	1.06
Volume	61K
Weekly RSI	39.38
YTD price change	-32.14%
YTD total return	-32.14%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	153.7M
Shares change (QoQ)	0.01%
Shares change (YoY)	8.72%
Shares held by insiders	14.68%
Shares outstanding	249.9M

Deeper analysis on CSE/GRIN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/GRIN report

Is a complete CSE/GRIN research report available?

No complete published report is available for cse/GRIN (CSE/GRIN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/GRIN (CSE/GRIN)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/GRIN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/GRIN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/GRIN

Frequently asked questions